RSS-Feed abonnieren
DOI: 10.1055/s-0030-1263319
© Georg Thieme Verlag KG Stuttgart · New York
Chronisch thromboembolische pulmonale Hypertonie
Empfehlungen der Kölner Konsensus-Konferenz 2010Chronic thromboembolic pulmonary hypertensionRecommendations of the Cologne Consensus Conference 2010Publikationsverlauf
eingereicht: 5.8.2010
akzeptiert: 9.9.2010
Publikationsdatum:
22. September 2010 (online)

Zusammenfassung
In der 2009 veröffentlichten Europäischen Leitlinie zur Diagnostik und Therapie der Pulmonalen Hypertonie (PH) wird unter anderem auf Aspekte der Pathophysiologie, Diagnostik und Therapie der chronisch thromboembolischen pulmonalen Hypertonie (CTEPH) eingegangen. Die korrekte Umsetzung der Leitlinie ist für das behandelte Krankheitsbild CTEPH von ganz entscheidender Bedeutung, da es sich um eine Form der PH handelt, die durch eine pulmonale Endarteriektomie (PEA) kurativ behandelbar sein kann, aber immer noch zu spät diagnostiziert und oft falsch therapiert wird. In der Leitlinie wird das Krankheitsbild relativ knapp behandelt, obwohl es eine häufige Form der pulmonalen Hypertonie ist. Jeder Patient mit PH unklarer Ursache sollte auf das Vorliegen einer CTEPH untersucht werden. Als Screening-Methode der Wahl wird eine Ventilations-Perfusionsszintigraphie empfohlen. Sobald eine Ventilations-Perfusionsszintigraphie oder CT-Angiographie Zeichen einer CTEPH zeigt, sollte der Patient in einem Zentrum vorgestellt werden, das Expertise in der medizinischen und chirurgischen Versorgung dieser Patienten hat. Nach Diagnosestellung einer CTEPH muss zur Beurteilung der Operabilität die Vorstellung bei einem erfahrenen PEA-Chirurgen erfolgen. Wesentliche Inhalte der Europäischen Leitlinie wurden kommentiert und bezüglich Diagnostik und Therapie ergänzt.
Abstract
In the 2009 European Guidelines on pulmonary hypertension one section covers aspects of pathophysiology, diagnosis and treatment of chronic thromboembolic pulmonary hypertension (CTEPH). The practical implementation of the guidelines for this disease is of crucial importance, because CTEPH is a form of pulmonary hypertension which can be surgically cured. It is, however, frequently diagnosed late in the course of disease and often treated not correctly. In the European Guidelines CTEPH is addressed relatively briefly, although it is a common form of PH which is often overlooked. Any patient with unexplained PH should be evaluated for the presence of CTEPH. A ventilation/perfusion lung scan is recommended as the first step to exclude CTEPH. If the ventilation/perfusion lung scan or multislice CT angiography reveals perfusions defects suggesting the diagnosis of CTEPH, the patient should be referred to a centre with expertise in the medical and surgical management of these patients. After diagnosis of CTEPH the case has to be reviewed by an experienced surgeon in a PEA centre for assessment of operability. The recommendations of the European guidelines are summarized in the current manuscript with additional comments regarding diagnosis and treatment according to most recent evidence.
Schlüsselwörter
chronisch thromboembolische pulmonale Hypertonie - Empfehlungen - Diagnostik - Therapie
Keywords
chronic thromboembolic pulmonary hypertension - guidelines - diagnosis - therapy
Literatur
- 1
Galie N, Hoeper M M, Humbert M. et al .
Guidelines for the diagnosis and treatment
of pulmonary hypertension. The task force for the diagnosis and
treatment of pulmonary hypertension of the European Society of Cardiology
(ESC) and the European Respiratory Society (ERS), endorsed by the
International Society of Heart and Lung Transplantation (ISHLT).
Eur Respir J.
2009;
34
1219-1263
MissingFormLabel
- 2
Hoeper M M, Ghofrani H A, Gorenflo M, Grünig E, Schranz D, Rosenkranz S.
Diagnostik und Therapie
der pulmonalen Hypertonie: Europäische Leitlinien 2009.
Pneumologie.
2010;
64
401-414
MissingFormLabel
- 3
Pengo V, Lensing A W, Prins M H, Marchiori A, Davidson B L, Tiozzo F. et
al .
Incidence of chronic thromboembolic pulmonary hypertension
after pulmonary embolism.
N Engl J Med.
2004;
350
2257-2264
MissingFormLabel
- 4
Lang I M.
Chronic thromboembolic pulmonary hypertension – not
so rare after all.
N Engl J Med.
2004;
350
2236
MissingFormLabel
- 5
Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani M R. et al .
Incidence
of chronic thromboembolic pulmonary hypertension after a first episode
of pulmonary embolism.
Chest.
2006;
130
172-175
MissingFormLabel
- 6
Hoeper M M, Mayer E, Simonneau G, Rubin L J.
Chronic thromboembolic pulmonary
hypertension.
Circulation.
2006;
113
2011-2020
MissingFormLabel
- 7
Fedullo P F, Auger W R, Kerr K M, Rubin L J.
Chronic
thromboembolic pulmonary hypertension.
N Engl J Med.
2001;
345
1465-1472
MissingFormLabel
- 8
Guidelines on diagnosis and
management of acute pulmonary embolism. Task Force on Pulmonary
Embolism European Society of Cardiology.
Eur Heart J.
2000;
21
1301-36
MissingFormLabel
- 9
Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D. et al .
Thrombotic
risk factors in pulmonary hypertension.
Eur Respir J.
2000;
15
395-399
MissingFormLabel
- 10
Bonderman D, Turecek P L, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B. et al .
High prevalence of elevated clotting factor VIII in chronic thromboembolic
pulmonary hypertension.
Thromb Haemost.
2003;
90
372-376
MissingFormLabel
- 11
Bonderman D, Wilkens H, Wakounig S, Schäfers H J, Jansa P, Lindner J. et al .
Risk factors for chronic thromboembolic pulmonary hypertension.
Eur Respir J.
2009;
33
325-331
MissingFormLabel
- 12
Ignatescu M, Kostner K, Zorn G, Kneussl M, Maurer G, Lang I M. et al .
Plasma Lp(a)
levels are increased in patients with chronic thromboembolic pulmonary
hypertension.
Thromb Haemost.
1998;
80
231-232
MissingFormLabel
- 13
Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle P A, Schonauer V. et al .
Medical
conditions increasing the risk of chronic thromboembolic pulmonary
hypertension.
Thromb Haemost.
2005;
93
512-516
MissingFormLabel
- 14
Jais X, Ioos V, Jardim C, Sitbon O, Parent F, Hamid A. et al .
Splenectomy
and chronic thromboembolic pulmonary hypertension.
Thorax.
2005;
60
1031-1034
MissingFormLabel
- 15
Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, Klepetko W, Kneussl M, Lang I M.
Predictors of outcome in chronic thromboembolic pulmonary hypertension.
Circulation.
2007;
115
2153-2158
MissingFormLabel
- 16
Bajc M, Neilly J B, Miniati M, Schuemichen C, Meignan M, Jonson B. EANM Committee .
EANM
guidelines for ventilation/perfusion scintigraphy: Part 1.
Pulmonary imaging with ventilation/perfusion single photon
emission tomography.
Eur J Nucl Med Mol Imaging.
2009;
36
1356-1370
MissingFormLabel
- 17
Bajc M, Neilly J B, Miniati M, Schuemichen C, Meignan M, Jonson B.
EANM guidelines for ventilation/perfusion
scintigraphy: Part 2. Algorithms and clinical considerations for
diagnosis of pulmonary emboli with V/P(SPECT) and MDCT.
Eur J Nucl Med Mol Imaging.
2009;
36
1528-1538
MissingFormLabel
- 18
Tunariu N, Gibbs S JR, Win Z. et al .
Ventilation-perfusion scintigraphy is more
sensitive than multidetector CTPA in detecting chronic thromboembolic
pulmonary disease as a treatable cause of pulmonary hypertension.
J Nucl Med.
2007;
48
680-684
MissingFormLabel
- 19
Dartevelle P, Fadel E, Mussot S. et al .
Chronic thromboembolic pulmonary hypertension.
Eur Respir J.
2004;
23
637-648
MissingFormLabel
- 20
Reichelt A, Hoeper M M, Galanski M. et al .
Chronic thromboembolic pulmonary hypertension:
evaluation with 64-detector row CT versus digital substraction angiography.
Eur J Radiol.
2009;
71
49-54
MissingFormLabel
- 21
Hoeper M M, Lee S H, Voswinckel R. et al .
Complications of right heart catheterization
procedures in patients with pulmonary hypertension in experienced
centers.
J Am Coll Cardiol.
2006;
48
2546-2552
MissingFormLabel
- 22
Kreitner K F, Kunz R P, Ley S. et al .
Chronic thromboembolic pulmonary
hypertension-assessment by magnetic resonance imaging.
Eur
Radiol.
2007;
17
11-21
MissingFormLabel
- 23
Shure D, Gregoratos G, Moser K M.
Fiberoptic angioscopy: role in the diagnosis of chronic pulmonary
arterial obstruction.
Ann Intern Med.
1985;
103
844-50
MissingFormLabel
- 24
Skoro-Sajer N, Hack N, Sadushi-Koliçi R, Bonderman D, Jakowitsch J, Klepetko W, Hoda M A, Kneussl M P, Fedullo P, Lang I M.
Pulmonary vascular reactivity and prognosis in patients with
chronic thromboembolic pulmonary hypertension: a pilot study.
Circulation.
2009;
119
298-305
MissingFormLabel
- 25
Kim N H, Fesler P, Channick R N, Knowlton K U, Ben-Yehuda O, Lee S H, Naeije R, Rubin L J.
Pre-operative
partitioning of pulmonary vascular resistance correlates with early
outcome following thromboendarterectomy for chronic thromboembolic
pulmonary hypertension.
Circulation.
2004;
109
18-22
MissingFormLabel
- 26
Bresser P, Fedullo P F, Auger W R. et al .
Continuous intravenous epoprostenol
for chronic thromboembolic pulmonary hypertension.
Eur
Respir J.
2004;
23
595-600
MissingFormLabel
- 27
Nagaya N, Sasaki N, Ando M. et
al .
Prostacyclin therapy before pulmonary thromboendarterectomy
in patients with chronic thromboembolic pulmonary hypertension.
Chest.
2003;
123
338-343
MissingFormLabel
- 28
Hoeper M M, Kramm T, Wilkens H. et al .
Bosentan therapy for inoperable chronic
thromboembolic pulmonary hypertension.
Chest.
2005;
128
2363-2367
MissingFormLabel
- 29
Hughes R, George P, Parameshwar J. et al .
Bosentan in inoperable chronic thromboembolic
pulmonary hypertension.
Thorax.
2005;
60
707
MissingFormLabel
- 30
Bonderman D, Nowotny R, Skoro-Sajer N. et al .
Bosentan therapy for inoperable chronic
thromboembolic pulmonary hypertension.
Chest.
2005;
128
2599-2603
MissingFormLabel
- 31
Reichenberger F, Voswinckel R, Enke B. et al .
Long-term treatment with sildenafil in
chronic thromboembolic pulmonary hypertension.
Eur Respir
J.
2007;
30
922-927
MissingFormLabel
- 32
Condliffe R, Kiely D G, Gibbs J S. et al .
Improved outcomes in medically
and surgically treated chronic thromboembolic pulmonary hypertension.
Am J Respir Crit Care Med.
2008;
177
1122-1127
MissingFormLabel
- 33
Seyfarth H J, Halank M, Wilkens H, Schäfers H J, Ewert R, Riedel M, Schuster E, Hammerschmidt S, Wirtz H.
Standard PAH therapy improves
long term survival in CTEPH patients.
Clinical Research
in Cardiology.
2010;
DOI: 10.1007/s00392–010–0156–4
MissingFormLabel
- 34
Jais X, D’Armini A M, Jansa P, Torbicki A, Delcroix M, Ghofrani H A, Hoeper M M, Lang I M, Mayer E, Pepke-Zaba J, Perchenet L, Morganti A, Simonneau G, Rubin L J.
Bosentan for treatment of inoperable chronic thromboembolic
pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms
of chronIc Thromboembolic pulmonary hypertension), a randomized,
placebo-controlled trial.
J Am Coll Cardiol.
2008;
52
2127-2134
MissingFormLabel
- 35
Thistlethwaite P A, Kaneko K, Madani M M, Jamieson S W.
Technique and outcomes of pulmonary endarterectomy surgery.
Ann Thorac Cardiovasc Surg.
2008;
14
274-282
MissingFormLabel
- 36
Jensen K W, Kerr K M, Fedullo P F, Kim N H, Test V J, Ben-Yehuda O, Auger W R.
Pulmonary hypertensive medical
therapy in chronic thromboembolic pulmonary hypertension before
pulmonary thromboendarterectomy.
Circulation.
2009;
120
1248-1254
MissingFormLabel
- 37
Hoeper M M, Barberà J A, Channick R N, Hassoun P M, Lang I M, Manes A, Martinez F J, Naeije R, Olschewski H, Pepke-Zaba J, Redfield M M, Robbins I M, Souza R, Torbicki A, McGoon M.
Diagnosis,
assessment, and treatment of non-pulmonary arterial hypertension
pulmonary hypertension.
J Am Coll Cardiol.
2009;
54
S85-96
MissingFormLabel
- 38
Galie N, Hoeper M M, Humbert M. et al .
Guidelines for the diagnosis and treatment
of pulmonary hypertension: The Task Force for the Diagnosis and
Treatment of Pulmonary Hypertension of the European Society of Cardiology
(ESC) and the European Respiratory Society (ERS), endorsed by the
International Society of Heart and Lung Transplantation (ISHLT).
Eur Heart J.
2009;
30
2493-2537
MissingFormLabel
Priv.-Doz. Dr. Heinrike Wilkens
Medizinische Klinik V
Universitätsklinikum des
Saarlandes
Kirrberger Straße
66421
Homburg/Saar
Telefon: 06841/16-23619
Fax: 06841/16-23645
eMail: heinrike.wilkens@uks.eu